Guidance for Iovance Biotherapeutics (IOVA)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| Q2 2026 | N/A | N/A | $86.00M – 88.00M | $84.36M | = Maintained | Details |
| 2025 | N/A | N/A | $250.00M – 300.00M | $287.10M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
